• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    AMETEK Announces Appointment of Karleen Oberton to Board of Directors

    2/11/21 8:00:00 AM ET
    $AME
    $HOLX
    Industrial Machinery/Components
    Industrials
    Medical Electronics
    Health Care
    Get the next $AME alert in real time by email

    BERWYN, Pa., Feb. 11, 2021 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has appointed Karleen Oberton as a new director of the Company. Ms. Oberton serves as Chief Financial Officer of Hologic, Inc. (NASDAQ: HOLX), an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment systems.

    "We are pleased to welcome Karleen to AMETEK as a member of our Board of Directors," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Karleen is a skilled business executive with more than 30 years of experience in public accounting, biotechnology and medical device manufacturing. Her strong financial acumen along with her proven executive leadership managing global organizations nicely complements our existing Board skill set."

    Joining Hologic as Vice President and Corporate Controller in 2006, Ms. Oberton has since held roles of increasing responsibility within the company's finance function. In 2014, she was named Corporate Vice President and Chief Accounting Officer and in 2018 was elected Chief Financial Officer. Prior to joining Hologic, Ms. Oberton served as Senior Corporate Controller for ImmunoGen, a biotechnology company developing targeted anticancer therapeutics. Earlier in her career, Ms. Oberton held leadership positions at Ernst & Young and Arthur Andersen.

    Ms. Oberton holds a bachelor's degree in Business Administration from Merrimack College and was an active Certified Public Accountant for more than 18 years.

    Corporate Profile
    AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2020 sales of more than $4.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.

    Contact:
    AMETEK, Inc.
    Kevin Coleman
    Vice President, Investor Relations
    1100 Cassatt Road
    Berwyn, Pennsylvania 19312
    [email protected]
    Phone: 610.889.5247

    SOURCE AMETEK, Inc.

    Related Links

    www.ametek.com

    Get the next $AME alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AME
    $HOLX

    CompanyDatePrice TargetRatingAnalyst
    AMETEK Inc.
    $AME
    4/14/2025$170.00Equal-Weight
    Morgan Stanley
    Hologic Inc.
    $HOLX
    3/3/2025Buy → Hold
    Argus
    Hologic Inc.
    $HOLX
    2/6/2025$80.00 → $75.00Outperform → Market Perform
    Leerink Partners
    Hologic Inc.
    $HOLX
    2/3/2025Buy → Hold
    Needham
    AMETEK Inc.
    $AME
    1/16/2025$210.00Neutral → Outperform
    Exane BNP Paribas
    AMETEK Inc.
    $AME
    12/16/2024$195.00 → $225.00Neutral → Buy
    BofA Securities
    Hologic Inc.
    $HOLX
    12/13/2024Peer Perform
    Wolfe Research
    Hologic Inc.
    $HOLX
    12/10/2024$90.00Buy
    Needham
    More analyst ratings

    $AME
    $HOLX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AMETEK Declares Quarterly Dividend

      BERWYN, Pa., May 8, 2025 /PRNewswire/ -- The Board of Directors of AMETEK, Inc. (NYSE:AME) declared a regular quarterly dividend of $0.31 per share for the second quarter ending June 30, 2025. This second quarter dividend is payable June 30, 2025 to shareholders of record as of June 13, 2025. Corporate ProfileAMETEK (NYSE:AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash gen

      5/8/25 8:00:00 AM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • NYSE Content Advisory: Pre-Market update + Federal Reserve begins two-day policy meeting

      NEW YORK, May 6, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on May 6th Stocks are looking at fractional losses early Tuesday as the Federal Reserve begins its two-day policy meeting. Markets anticipate that the central bank will keep rates steady when it delivers its decision.Treasury Secretary Scott Bessent told CNBC Monday that the U.S. is very close to new trade deals. According to Bloomberg, India has proposed zero tariffs on certain goods.Semicon

      5/6/25 8:55:00 AM ET
      $AME
      $ICE
      Industrial Machinery/Components
      Industrials
      Investment Bankers/Brokers/Service
      Finance
    • AMETEK to Acquire FARO Technologies

      BERWYN, Pa., and LAKE MARY, Fla., May 6, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) and FARO Technologies, Inc. (NASDAQ:FARO) today announced that they have entered into a definitive agreement under which AMETEK will acquire all outstanding shares of FARO Technologies common stock for $44 per share in cash, which represents an approximate 40% premium to FARO's closing price on May 5, 2025. The transaction values FARO at an enterprise value of approximately $920 million. The boards of directors of both companies have unanimously approved the transaction. Founded in 1981 and headquartered in Lake Mary, Florida, FARO Technologies is a leading provider of 3D measurement and imaging solutions,

      5/6/25 7:30:00 AM ET
      $AME
      $FARO
      Industrial Machinery/Components
      Industrials

    $AME
    $HOLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley initiated coverage on Ametek with a new price target

      Morgan Stanley initiated coverage of Ametek with a rating of Equal-Weight and set a new price target of $170.00

      4/14/25 8:15:39 AM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • Hologic downgraded by Argus

      Argus downgraded Hologic from Buy to Hold

      3/3/25 8:06:16 AM ET
      $HOLX
      Medical Electronics
      Health Care
    • Hologic downgraded by Leerink Partners with a new price target

      Leerink Partners downgraded Hologic from Outperform to Market Perform and set a new price target of $75.00 from $80.00 previously

      2/6/25 7:06:39 AM ET
      $HOLX
      Medical Electronics
      Health Care

    $AME
    $HOLX
    SEC Filings

    See more
    • AMETEK Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - AMETEK INC/ (0001037868) (Filer)

      5/8/25 2:25:29 PM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • AMETEK Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - AMETEK INC/ (0001037868) (Filer)

      5/8/25 1:38:53 PM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • SEC Form 10-Q filed by Hologic Inc.

      10-Q - HOLOGIC INC (0000859737) (Filer)

      5/2/25 8:05:04 AM ET
      $HOLX
      Medical Electronics
      Health Care

    $AME
    $HOLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hologic Inc.

      SC 13G/A - HOLOGIC INC (0000859737) (Subject)

      11/14/24 1:28:29 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • SEC Form SC 13G filed by Hologic Inc.

      SC 13G - HOLOGIC INC (0000859737) (Subject)

      2/14/24 10:04:34 AM ET
      $HOLX
      Medical Electronics
      Health Care
    • SEC Form SC 13G/A filed by AMETEK Inc. (Amendment)

      SC 13G/A - AMETEK INC/ (0001037868) (Subject)

      2/13/24 4:58:53 PM ET
      $AME
      Industrial Machinery/Components
      Industrials

    $AME
    $HOLX
    Leadership Updates

    Live Leadership Updates

    See more
    • AMETEK to Acquire FARO Technologies

      BERWYN, Pa., and LAKE MARY, Fla., May 6, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) and FARO Technologies, Inc. (NASDAQ:FARO) today announced that they have entered into a definitive agreement under which AMETEK will acquire all outstanding shares of FARO Technologies common stock for $44 per share in cash, which represents an approximate 40% premium to FARO's closing price on May 5, 2025. The transaction values FARO at an enterprise value of approximately $920 million. The boards of directors of both companies have unanimously approved the transaction. Founded in 1981 and headquartered in Lake Mary, Florida, FARO Technologies is a leading provider of 3D measurement and imaging solutions,

      5/6/25 7:30:00 AM ET
      $AME
      $FARO
      Industrial Machinery/Components
      Industrials
    • AMETEK Appoints Jennifer G. Hellberg Vice President, Human Resources

      BERWYN, Pa., March 3, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of Jennifer G. Hellberg as Vice President, Human Resources. Ms. Hellberg most recently served as Divisional Vice President and Business Unit Manager for the Zygo and Navitar businesses within AMETEK's Ultra Precision Technologies Division. "I am pleased to announce Jennifer's promotion to Vice President, Human Resources," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Jennifer has demonstrated outstanding leadership and strategic vision during her time at AMETEK. I am confident she will continue to enhance our global human resources organization and support AMETEK's l

      3/3/25 8:00:00 AM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • AMETEK Appoints William P. Callahan Vice President and General Manager, Aerospace & Defense Division

      BERWYN, Pa., Feb. 7, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of William P. Callahan as Vice President and General Manager, Aerospace & Defense Division.   "I am delighted to welcome Bill to AMETEK and pleased he will be taking on this important leadership role with the company," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Bill's extensive P&L management experience, strong operational expertise, and proven leadership skills make him ideally suited for this role." Mr. Callahan brings a strong track record of experience and success, having most recently served as Group General Manager at Amphenol Corporation. Prior to that, Mr.

      2/7/25 8:00:00 AM ET
      $AME
      Industrial Machinery/Components
      Industrials

    $AME
    $HOLX
    Financials

    Live finance-specific insights

    See more
    • AMETEK Declares Quarterly Dividend

      BERWYN, Pa., May 8, 2025 /PRNewswire/ -- The Board of Directors of AMETEK, Inc. (NYSE:AME) declared a regular quarterly dividend of $0.31 per share for the second quarter ending June 30, 2025. This second quarter dividend is payable June 30, 2025 to shareholders of record as of June 13, 2025. Corporate ProfileAMETEK (NYSE:AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash gen

      5/8/25 8:00:00 AM ET
      $AME
      Industrial Machinery/Components
      Industrials
    • Hologic Announces Financial Results for Second Quarter of Fiscal 2025

      – Revenue of $1,005.3 Million Slightly Exceeds Guidance – – Company Reports GAAP Diluted EPS of ($0.08); Non-GAAP Diluted EPS of $1.03 at High End of Guidance – – Company Maintains Annual Revenue Guidance, Lowers Guidance for GAAP and Non-GAAP EPS – Hologic, Inc. (NASDAQ:HOLX) announced today the Company's financial results for the fiscal second quarter ended March 29, 2025. "We delivered on our financial commitments in the second quarter," said Stephen P. MacMillan, the Company's Chairman, President and Chief Executive Officer. "Both revenue and non-GAAP EPS finished at the high ends of our guidance ranges, driven by our diagnostics and skeletal businesses, strong profitability, share

      5/1/25 4:01:00 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • AMETEK Announces First Quarter Results

      BERWYN, Pa., May 1, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced its financial results for the first quarter ended March 31, 2025. AMETEK's first quarter 2025 sales were $1.73 billion, in-line with the first quarter of 2024 sales. Operating income increased 2% to $454.8 million, and operating margins were up 60 basis points to 26.3%, both versus prior year's adjusted results. Free cash flow to net income conversion was 112% in the quarter. On a GAAP basis, first quarter earnings per diluted share were $1.52. Adjusted earnings in the quarter were $1.75 per diluted share, up 7% from the first quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related

      5/1/25 6:55:00 AM ET
      $AME
      Industrial Machinery/Components
      Industrials

    $AME
    $HOLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      5/9/25 4:39:33 PM ET
      $HOLX
      Medical Electronics
      Health Care

    $AME
    $HOLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      5/9/25 4:39:33 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • New insider Liddy Anne M. claimed ownership of 11,426 shares (SEC Form 3)

      3 - HOLOGIC INC (0000859737) (Issuer)

      5/2/25 4:52:34 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • Director Mcmillan Wayde D. was granted 1,742 shares (SEC Form 4)

      4 - HOLOGIC INC (0000859737) (Issuer)

      4/9/25 4:16:43 PM ET
      $HOLX
      Medical Electronics
      Health Care

    $AME
    $HOLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 29, 2024 - FDA Roundup: October 29, 2024

      For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

      10/29/24 3:30:19 PM ET
      $HOLX
      Medical Electronics
      Health Care
    • February 2, 2024 - FDA Roundup: February 2, 2024

      For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

      2/2/24 3:58:21 PM ET
      $HOLX
      Medical Electronics
      Health Care